The review discusses accumulated to date scientific data on dilated cardiomyopathy: causative factors, clinical manifestations, sudden cardiac death in patients with the disease and its risk-stratification in the light of National guidelines on the definition of risk and prevention of sudden cardiac death (2012). A case of a patient with dilated cardiomyopathy and high-risk of sudden cardiac death is presented.


  1. Национальные рекомендации по определению риска и профилактике внезапной сердечной смерти. Клиническая практика №4, 2012.
  2. Hershberger R.E., Kushner J.D., Parks S.B. Dilated Cardiomyopathy Overview. GeneReviews. Seattle (WA): University of Washington, Seattle; 1993-2007 Jul 27.
  3. Mahon N.G., Murphy R.T., MacRae C.A. et al. Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Inter Med 2005;143(2):108-15.
  4. Baig M.K., Goldman J.H., Caforio A.,L. et al. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 1998; 31 (1): 195-201.
  5. Grunig E., Tasman J.A., Kucherer H. et al. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998; 31 (1): 186-94.
  6. Fuster V., Gersh B.J., Giuliani E.R. et al. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47: 525-38.
  7. Coughlin S.S., Neaton J.D., Sengupta A. et al. Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol 1994; 139: 166-72.
  8. Dec G.W., Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331:1564-75.
  9. Di L.A., Secoli G., Perkan A. et al. Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group. Br Heart J 1994; 72: 46-51.
  10. Sugrue D.D., Rodeheffer R.J., Codd M.B. et al. The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann Intern Med 1992;117: 117-23.
  11. Huikuri H.V., Castellanos A., Myerburg R.J. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-82.
  12. Felker G.M., Thompson R.E., Hare J.M. et al.Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-84.
  13. Baba A., Yoshikawa T., Ogawa S. Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 1153-9.
  14. Yu H., Pei J., Lui X. et al. Calcium channel autoantibodies predicted sudden cardiac death and all-cause mortality in patients with ischemic and nonischemic chronic heart failure. Dis markers 2014.
  15. Zimetbaum P.J., Buxton A.E., Batsford W. et al. Electrocardiographic predictors of arrhythmic death and totalmortality in the multicenter unsustained tachycardia trial.Circulation 2004; 110 (7):766-9.
  16. Xiao H., Wang M., Du Y. et al. Arrhythmogenic autoantibodies against calcium channel lead to sudden death in idiopathic dilated cardiomyopathy. Eur J of Heart Failure 2011; 13: 264-70.
  17. Kimura A. Contribution of genetic factors to the pathogenesis of dilated cardiomyopathy. Circ J 2011; 75: 1756-65.
  18. Towbin J.A., Hejtmancik J.F., Brink P. et al. X-linked dilated cardiomyopathy: molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993; 87: 1854-65.
  19. Hershberger R.E., Cowan J., Morales A., Siegfried J.D. Progress with genetic cardiomyopathies screening, counseling, and testing in dilated, hyper-trophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail 2009; 2: 253-61.
  20. Moolman-Smook J.C., Mayosi B.M., Brink P.A., Corfield V.A. Molecular genetics of cardiomyopathy: changing times, shifting paradigms. Cardiovasc J S Afr 2003;14:145-55.
  21. Mestroni L., Rocco C., Gregori D. et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol. 1999;34: 181-90.
  22. Bowles N.E., Bowles K.R., Towbin J.A. The final common pathway hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz 2000;25:168-75.
  23. Charron P., Arad M., Arbustini E. et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working group on Myocardial and Pericardial Diseases. Eur J Heart 2010; 31: 2715-28.
  24. Grimm W., Michael Christ M., Jennifer Bach J. et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 2003; 108: 2883-91.
  25. Grimm W., Alter P., Maisch B. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE and SCD-HeFT. Herz 2004; 29 (3): 348-52.
  26. Voss A., Schroder R., Trubner S. et al. Comparison of nonlinear methods symbolic dynamics, detrended fluctuation, and Poincare plot analysis in risk stratification in patients with dilated cardiomyopathy. CHAOS 2007; 17.
  27. Assomull R.G., Prasad S.K., Lyne J. et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48:1977-85.
  28. Bansch D., Antz M., Boczor S. et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 2002; 105:1453-58.
  29. Kadish A., Dyer A., Daubert J.P. et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-8.
  30. Bardy G.H., Lee K.L., Mark D.B. et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37.
  31. Parcash R., Stevenson W.G., Epstein L.M., Maisel W.H. Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection. Am Heart J 2006; 151:397-403.
  32. Schefer T., Wolber T., Binggeli C. et al. Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function. Europace. 2008 Sep;10(9):1052-9.



Abstract: 214

PDF (Russian): 234

Article Metrics

Metrics Loading ...


Copyright (c) 2014 Duplyakov D.V., Kondratyeva I.V., Garkina S.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies